Current Size: 100%


First LBG Meeting for HEALTH SCIENCES 2013

After three successful and multidisciplinary „Meet Science“ events of the LBG, the idea was born to set up a special meeting for all Ludwig Boltzmann Institutes and Clusters, who are active in the area of medicine and life sciences as well as its related disciplines. The main purpose of such a meeting: to get to know each other’s research, to establish new cooperations under the roof of the LBG and to inform the medical community/public about the health related LBG activities. The common denominator of the participating institutes and clusters is also the namesake of the meeting: Health Sciences
With this meeting the LBG sets a mark to promote its core topic health sciences, which is defined as one of the LBG’s special characteristics besides the promotion of translational research and the strong inter- and transdisciplinarity of all Ludwig Boltzmann Institutes and Clusters.

LBG Weinherbst

As a science policy forum the Ludwig Boltzmann Gesellschaft (LBG) asked  for the first time researchers, policy makers and journalists to get together for the "Weinherbst" on the 20th Floor of the new Raiffeisen building in the heart of Vienna. The impressive panorama presented the backdrop for an inspiring meeting of science and research community. President of LBG Josef Pröll and science and research minister Univ.-Prof. Dr. Karlheinz Töchterle welcomed the numerous guests.


Workshop on Advances in Myeloproliferative Neoplasms

International experts in the area of myeloproliferative disease presented partly unpublished results ranging from basic research of molecular genetics to the study of mechanisms of neoplastic transformation and evolution of myeloproliferative disorders. In accordance with "Bench to Bedside" strategies and the value of new molecular targets for novel therapeutic approaches clinicians and biomedical scientists discussed thier results. Special attention was paid to the neoplastic cells of myeloproliferative diseases, and especially also the mast cell leukemias, which are now also assigned to the myeloproliferative disorders.

Invited Speaker Seminar: Next Generation Sequencing transforms health research

Andreas Sommer, head of genomics at the Campus Support Facility (CSF), gave an introduction to the tecnological advances in modern genetics and highlighted the capabilities and options available to external researchers. At a subseqent get together members of the LBI-CR explored access to the facilities and discussed differernt technological options. All in all the Seminar provided a stimulating reminder to include modern genomics technologies into the research approaches of the LBI-CR.